Evidence map›Paper›PMID 31205627›Full record

ArticleInternational journal of hematology-oncology and stem cell research2019

Hepcidin and

Kiavash Fekri, Negar Asle Rasouli, Seyyed Abdolhossein Tavallai Zavareh, Milad Jalil, Fahimeh Moradi, Maryam Hosseinpour, Hossein Teimori

Open access · diamondAbstract read
PubMed Full text at PMC
In one paragraph

Article in International journal of hematology-oncology and stem cell research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kiavash FekriCancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Negar Asle RasouliMedical Biotechnology, Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Seyyed Abdolhossein Tavallai ZavarehDepartment of Pediatrics, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Milad JalilMolecular Genetics, Tehran Medical Branch, Islamic Azad University, Tehran, Iran.
Fahimeh MoradiHuman Genetics, Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Maryam HosseinpourMolecular Genetics, Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Hossein TeimoriMedical Genetics, Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Shahrekord University of Medical Sciences · IRIslamic Azad University Medical Branch of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FerritinHepcidinHFE* Iron overloadThalassemia

Identifiers

PMID31205627
PMCPMC6557969
OpenAlexW2911176029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.